ProQR Therapeutics Correlations

PRQR Stock  USD 2.37  0.07  3.04%   
The current 90-days correlation between ProQR Therapeutics and Annexon is -0.11 (i.e., Good diversification). The correlation of ProQR Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

ProQR Therapeutics Correlation With Market

Average diversification

The correlation between ProQR Therapeutics BV and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProQR Therapeutics BV and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProQR Therapeutics BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Moving together with ProQR Stock

  0.67SPRY Silverback TherapeuticsPairCorr
  0.65VMD Viemed HealthcarePairCorr
  0.68UTMD Utah Medical Products Earnings Call Next WeekPairCorr
  0.73BKRKY Bank RakyatPairCorr
  0.77PPERY Bank Mandiri PerseroPairCorr
  0.75PPERF Bank Mandiri PerseroPairCorr
  0.7PBCRY Bank Central Asia Earnings Call This WeekPairCorr
  0.65PTBRY Bank Negara Indonesia Earnings Call This WeekPairCorr
  0.75TRV The Travelers CompaniesPairCorr
  0.69XOM Exxon Mobil Corp Aggressive PushPairCorr

Moving against ProQR Stock

  0.56MBFJF Mitsubishi UFJ FinancialPairCorr
  0.75BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.67OPFI OppFi IncPairCorr
  0.59EXEEW Expand Energy Symbol ChangePairCorr
  0.44MZHOF Mizuho FinancialPairCorr
  0.4IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.4WMT WalmartPairCorr
  0.3517298CHT8 US17298CHT80PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SPRODAWN
SPROTERN
TERNDAWN
ALNYDAWN
WVETERN
SPROALNY
  
High negative correlations   
APLSANNX
APLSALNY
BPMCWVE
ASMBBPMC
SPROAPLS
BPMCTERN

Risk-Adjusted Indicators

There is a big difference between ProQR Stock performing well and ProQR Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProQR Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANNX  2.51 (0.80) 0.00  30.84  0.00 
 3.73 
 22.26 
ARWR  2.83  0.01  0.00  0.03  4.28 
 4.88 
 35.58 
DAWN  1.80 (0.23) 0.00 (0.27) 0.00 
 3.92 
 11.05 
TERN  3.16 (0.77) 0.00 (5.21) 0.00 
 5.17 
 26.61 
ALNY  1.65 (0.29) 0.00 (0.59) 0.00 
 2.91 
 15.40 
WVE  4.26  0.69  0.16  1.09  3.73 
 7.68 
 84.19 
BPMC  2.14  0.42  0.16  0.52  2.19 
 5.87 
 19.12 
APLS  2.59  0.18  0.04  0.20  3.79 
 4.63 
 27.73 
ASMB  2.74 (0.17) 0.00  2.11  0.00 
 5.74 
 24.82 
SPRO  2.55 (0.49) 0.00 (1.78) 0.00 
 5.56 
 17.35 

ProQR Therapeutics Corporate Management

Aniz MDChief OfficerProfile
Domenico ValerioFounder BoardProfile
Sarah KielyVice CommunicationsProfile
Rene BeukemaChief Corporate Devel. Officer, General Counsel, Corporate Secretary and Member of Management BoardProfile
Sheila SponseleeVP OperationsProfile
Gerard PlatenburgChief Innovation OfficerProfile